China National Accord Medicines Corporation Ltd.

Informe acción SZSE:000028

Capitalización de mercado: CN¥15.0b

China National Accord Medicines Dirección

Dirección controles de criterios 3/4

We currently do not have sufficient information about the CEO.

Información clave

Zhaoxiong Lin

Chief Executive Officer (CEO)

CN¥2.6m

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEO8.7yrs
Participación del CEOn/a
Permanencia media de la dirección5.4yrs
Promedio de permanencia en la Junta Directiva3.7yrs

Actualizaciones recientes de la dirección

Recent updates

China National Accord Medicines Corporation Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Oct 30
China National Accord Medicines Corporation Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

China National Accord Medicines (SZSE:000028) Seems To Use Debt Quite Sensibly

Oct 10
China National Accord Medicines (SZSE:000028) Seems To Use Debt Quite Sensibly

China National Accord Medicines Corporation Ltd.'s (SZSE:000028) Low P/E No Reason For Excitement

Aug 13
China National Accord Medicines Corporation Ltd.'s (SZSE:000028) Low P/E No Reason For Excitement

Estimating The Intrinsic Value Of China National Accord Medicines Corporation Ltd. (SZSE:000028)

Jul 12
Estimating The Intrinsic Value Of China National Accord Medicines Corporation Ltd. (SZSE:000028)

Is China National Accord Medicines (SZSE:000028) A Risky Investment?

Jun 12
Is China National Accord Medicines (SZSE:000028) A Risky Investment?

Improved Earnings Required Before China National Accord Medicines Corporation Ltd. (SZSE:000028) Shares Find Their Feet

May 12
Improved Earnings Required Before China National Accord Medicines Corporation Ltd. (SZSE:000028) Shares Find Their Feet

Analysts Are Updating Their China National Accord Medicines Corporation Ltd. (SZSE:000028) Estimates After Its Full-Year Results

Apr 10
Analysts Are Updating Their China National Accord Medicines Corporation Ltd. (SZSE:000028) Estimates After Its Full-Year Results

China National Accord Medicines Corporation Ltd. (SZSE:000028) Shares Could Be 28% Below Their Intrinsic Value Estimate

Mar 15
China National Accord Medicines Corporation Ltd. (SZSE:000028) Shares Could Be 28% Below Their Intrinsic Value Estimate

China National Accord Medicines (SZSE:000028) Has A Rock Solid Balance Sheet

Feb 29
China National Accord Medicines (SZSE:000028) Has A Rock Solid Balance Sheet

CEO

Zhaoxiong Lin (57 yo)

8.7yrs

Permanencia

CN¥2,550,000

Compensación

Mr. Zhaoxiong Lin, MBA has been General Manager of Sinopharm Medicine Holding Guangzhou Co., Ltd since December 2006. Mr. Lin has been General Manager of China National Accord Medicines Corporation Ltd. si...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Zhaoxiong Lin
GM & Non-Independent Director8.7yrsCN¥2.55msin datos
Guolin Gu
Deputy GM4.5yrsCN¥1.66msin datos
Baochun Lang
General Counsel6.3yrsCN¥1.79msin datos
Chuan Li
Deputy GM & Board Secretaryless than a yearsin datossin datos
Changbing Chen
Deputy General Managerno dataCN¥1.66m0.00062%
CN¥ 93.1k

5.4yrs

Permanencia media

56yo

Promedio de edad

Equipo directivo experimentado: 000028's management team is seasoned and experienced (5.4 years average tenure).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Zhaoxiong Lin
GM & Non-Independent Director8.6yrsCN¥2.55msin datos
Yong Liu
Director7.8yrssin datossin datos
Jinxiong Li
Non-Independent Directorless than a yearsin datossin datos
Yijian Wu
Chairman of the board4yrssin datossin datos
Deyong Wen
Chairman of the Board of Supervisors5.5yrssin datossin datos
Weiwei Su
Independent Director5.8yrsCN¥250.00ksin datos
Guojing Chen
Employee Supervisor6.3yrssin datossin datos
Xiaojuan Li
Non-Independent Director3.4yrssin datossin datos
Honghai Li
Independent Directorless than a yearsin datossin datos
Yalin Bi
Independent Directorless than a yearsin datossin datos
Haiqing Lu
Supervisorless than a yearsin datossin datos
Bailing Jiang
Independent Directorless than a yearsin datossin datos

3.7yrs

Permanencia media

54yo

Promedio de edad

Junta con experiencia: 000028's board of directors are considered experienced (3.7 years average tenure).